BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38049248)

  • 1. Percutaneous ablation of renal tumors: Long-term outcomes.
    Del Cura Rodríguez JL; Zabala-Landa R; Korta-Gomez I
    Radiologia (Engl Ed); 2023; 65(6):492-501. PubMed ID: 38049248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters.
    Best SL; Park SK; Youssef RF; Olweny EO; Tan YK; Trimmer C; Cadeddu JA
    J Urol; 2012 Apr; 187(4):1183-9. PubMed ID: 22335865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
    De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
    Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of expandable electrodes in percutaneous radiofrequency ablation of renal cell carcinoma.
    Gulesserian T; Mahnken AH; Schernthaner R; Memarsadeghi M; Weber M; Tacke A; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):133-9. PubMed ID: 16837160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
    J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
    Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
    Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
    J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
    Cool DW; Kachura JR
    J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy: Degree of Enhancement Matters.
    Lay AH; Stewart J; Canvasser NE; Cadeddu JA; Gahan JC
    J Urol; 2016 Jul; 196(1):41-5. PubMed ID: 26826583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
    Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
    J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
    Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
    J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.